Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.
Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check13 days agoChange DetectedThe website has been updated from version 2.10.3 to 2.11.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check56 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2.SummaryDifference0.1%
- Check77 days agoChange DetectedThe website has added information about 3 more interventions/treatments and updated the study to include 73 locations, while also revising the version from v2.9.7 to v2.10.0.SummaryDifference0.5%
- Check84 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.